Skip to content

All Industry Workshops take place on Tuesday, March 26, 2019 from 11:30am – 12:30pm. 

AMCP Industry Workshops with a   include preapproval information exchange information.  Subject to federal laws and regulations, attendance at these sessions is restricted to payors, formulary committee, or other similar entity representatives with knowledge and expertise in the area of health care economic analysis, carrying out responsibilities for the selection of drugs for coverage or reimbursement. For more information, visit our website.

Tuesday, March 26, 2019 

 

Perspectives in Treatment-Resistant Depression

Hosted by Janssen Pharmaceuticals, Inc.
11:30am – 12:30pm / Room: 16AB

One third of patients with major depressive disorder do not achieve remission despite multiple treatment steps. Unmet needs remain in adult patients suffering from treatment-resistant depression.

Multiple Sclerosis: New Perspectives on the Patient Journey – 2019 Update

Hosted by Biogen
11:30am – 12:30pm / Room: 15AB

Biogen has joined together with Milliman, Inc., a well-known source of actuarial expertise for the healthcare industry, to develop a white paper titled Multiple Sclerosis: New Perspectives on the Patient Journey – 2019 Update, which presents the findings of a commercial claims analysis of more than 10 years’ duration (2006 to 2017). This analysis is the update to a white paper about the multiple sclerosis (MS) patient journey, released in 2016.

Key topics of the discussion will include:
• Prevalence and incidence of MS
• Use of disease-modifying therapies (DMTs)-including use vs nonuse, adherence, and switching (joint decision by patient and HCP due to the heterogeneity of MS)
• Clinical course of MS, including relapses and indicators of disability and neurologic impairment
• Potential cost implications of treatment inclusive of DMT and non-DMT costs

This study was conducted by Milliman, Inc., and commissioned by Biogen, Inc., February 2019.

Presenter: Bruce S. Pyenson, FSA, MAAA, Principle, Consulting Actuary, Milliman, Inc., Fellow, Society of Actuaries, Member, American Academy of Actuaries